Richter, F., Williams-Fairless, S. K., John, K., Huber, C., Vaslin, C., Zanker, H., . . . Fischer, R. (2021). The TNFR1 antagonist atrosimab is therapeutic in mouse models of acute and chronic inflammation. Frontiers in immunology, 12, . https://doi.org/10.3389/fimmu.2021.705485
Chicago-Zitierstil (17. Ausg.)Richter, Fabian, et al. "The TNFR1 Antagonist Atrosimab Is Therapeutic in Mouse Models of Acute and Chronic Inflammation." Frontiers in Immunology 12 (2021). https://doi.org/10.3389/fimmu.2021.705485.
MLA-Zitierstil (9. Ausg.)Richter, Fabian, et al. "The TNFR1 Antagonist Atrosimab Is Therapeutic in Mouse Models of Acute and Chronic Inflammation." Frontiers in Immunology, vol. 12, 2021, https://doi.org/10.3389/fimmu.2021.705485.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.